2. Jarolimova J, Tagoni J, Stern TA. Obesity: its epidemiology, comorbidities, and management. Prim Care Companion CNS Disord 2013 15:PCC.12f01475.
[CROSSREF]
3. Gallagher EJ, LeRoith D. Obesity and diabetes: the increased risk of cancer and cancer-related mortality. Physiol Rev 2015;95:727-48.
[CROSSREF] [PUBMED] [PMC]
4. Nam GE, Kim YH, Han K, Jung JH, Rhee EJ, Lee WY, et al. Obesity fact sheet in Korea, 2020: prevalence of obesity by obesity class from 2009 to 2018. J Obes Metab Syndr 2021;30:141-8.
[CROSSREF] [PUBMED] [PMC]
5. Bhupathiraju SN, Hu FB. Epidemiology of obesity and diabetes and their cardiovascular complications. Circ Res 2016;118:1723-35.
[CROSSREF] [PUBMED] [PMC]
6. Lim S. Ectopic fat assessment focusing on cardiometabolic and renal risk. Endocrinol Metab (Seoul) 2014;29:1-4.
[CROSSREF] [PUBMED] [PMC]
7. Bays HE. “Sick fat,” metabolic disease, and atherosclerosis”. Am J Med 2009;122(1 Suppl):S26-37.
[CROSSREF] [PUBMED]
8. Lee YH, Han K, Ko SH, Ko KS, Lee KU; Taskforce Team of Diabetes Fact Sheet of the Korean Diabetes Association. Data analytic process of a nationwide population-based study using national health information database established by National Health Insurance Service. Diabetes Metab J 2016;40:79-82.
[CROSSREF] [PUBMED] [PMC]
9. Jung CH, Son JW, Kang S, Kim WJ, Kim HS, Kim HS, et al. Diabetes fact sheets in Korea, 2020: an appraisal of current status. Diabetes Metab J 2021;45:1-10.
[CROSSREF] [PUBMED] [PMC]
10. Kim HC, Cho SMJ, Lee H, Lee HH, Baek J, Heo JE, et al. Korea hypertension fact sheet 2020: analysis of nationwide population-based data. Clin Hypertens 2021;27:8.
[CROSSREF] [PUBMED] [PMC]
11. Rhee EJ. Prevalence and current management of cardiovascular risk factors in Korean adults based on fact sheets. Endocrinol Metab (Seoul) 2020;35:85-94.
[CROSSREF] [PUBMED] [PMC]
13. Eckel RH, Grundy SM, Zimmet PZ. The metabolic syndrome. Lancet 2005;365:1415-28.
[CROSSREF] [PUBMED]
14. Alberti KG, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA, et al. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 2009;120:1640-5.
[PUBMED]
15. Brown WV. Different definitions of the metabolic syndrome and risk for recurrent cardiovascular disease. Nat Clin Pract Endocrinol Metab 2006;2:492-3.
[CROSSREF] [PUBMED]
16. Lee WY, Park JS, Noh SY, Rhee EJ, Kim SW, Zimmet PZ. Prevalence of the metabolic syndrome among 40,698 Korean metropolitan subjects. Diabetes Res Clin Pract 2004;65:143-9.
[CROSSREF] [PUBMED]
17. Kondo T, Osugi S, Shimokata K, Honjo H, Morita Y, Yamashita K, et al. Metabolic syndrome and all-cause mortality, cardiac events, and cardiovascular events: a follow-up study in 25,471 young- and middle-aged Japanese men. Eur J Cardiovasc Prev Rehabil 2011;18:574-80.
[CROSSREF] [PUBMED]
18. Ford ES. The metabolic syndrome and mortality from cardiovascular disease and all-causes: findings from the National Health and Nutrition Examination Survey II Mortality Study. Atherosclerosis 2004;173:309-14.
[CROSSREF] [PUBMED]
19. Sung KC, Rhee EJ, Ryu S, Kim BJ, Kim BS, Lee WY, et al. Increased cardiovascular mortality in subjects with metabolic syndrome is largely attributable to diabetes and hypertension in 159,971 Korean adults. J Clin Endocrinol Metab 2015;100:2606-12.
[PUBMED]
20. Seo MH, Rhee EJ. Metabolic and cardiovascular implications of a metabolically healthy obesity phenotype. Endocrinol Metab (Seoul) 2014;29:427-34.
[CROSSREF] [PUBMED] [PMC]
21. Rumberger JA, Simons DB, Fitzpatrick LA, Sheedy PF, Schwartz RS. Coronary artery calcium area by electron-beam computed tomography and coronary atherosclerotic plaque area. A histopathologic correlative study. Circulation 1995;92:2157-62.
[CROSSREF] [PUBMED]
22. Detrano R, Guerci AD, Carr JJ, Bild DE, Burke G, Folsom AR, et al. Coronary calcium as a predictor of coronary events in four racial or ethnic groups. N Engl J Med 2008;358:1336-45.
[CROSSREF] [PUBMED]
23. Blankstein R, Gupta A, Rana JS, Nasir K. The implication of coronary artery calcium testing for cardiovascular disease prevention and diabetes. Endocrinol Metab (Seoul) 2017;32:47-57.
[CROSSREF] [PUBMED] [PMC]
24. Rhee EJ, Seo MH, Kim JD, Jeon WS, Park SE, Park CY, et al. Metabolic health is more closely associated with coronary artery calcification than obesity. PLoS One 2013;8:e74564.
[CROSSREF] [PUBMED] [PMC]
25. Rhee EJ, Lee MK, Kim JD, Jeon WS, Bae JC, Park SE, et al. Metabolic health is a more important determinant for diabetes development than simple obesity: a 4-year retrospective longitudinal study. PLoS One 2014;9:e98369.
[CROSSREF] [PUBMED] [PMC]
26. Smith GI, Mittendorfer B, Klein S. Metabolically healthy obesity: facts and fantasies. J Clin Invest 2019;129:3978-89.
[CROSSREF] [PUBMED] [PMC]
27. Aronson D, Rayfield EJ. How hyperglycemia promotes atherosclerosis: molecular mechanisms. Cardiovasc Diabetol 2002;1:1.
[PUBMED] [PMC]
28. Rhee EJ, Park SE, Chang Y, Ryu S, Lee WY. Baseline glycemic status and mortality in 241,499 Korean metropolitan subjects: a Kangbuk Samsung Health Study. Metabolism 2016;65:68-77.
[CROSSREF] [PUBMED]
29. Rhee EJ, Kim JH, Park HJ, Park SE, Oh HG, Park CY, et al. Increased risk for development of coronary artery calcification in insulin-resistant subjects who developed diabetes: 4-year longitudinal study. Atherosclerosis 2016;245:132-8.
[CROSSREF] [PUBMED]
30. Kershaw EE, Flier JS. Adipose tissue as an endocrine organ. J Clin Endocrinol Metab 2004;89:2548-56.
[CROSSREF] [PUBMED]
31. Adams LA, Anstee QM, Tilg H, Targher G. Non-alcoholic fatty liver disease and its relationship with cardiovascular disease and other extrahepatic diseases. Gut 2017;66:1138-53.
[CROSSREF] [PUBMED]
32. Rhee EJ. Nonalcoholic fatty liver disease and diabetes: an epidemiological perspective. Endocrinol Metab (Seoul) 2019;34:226-33.
[CROSSREF] [PUBMED] [PMC]
33. Jung CH, Rhee EJ, Kwon H, Chang Y, Ryu S, Lee WY. Visceral-to-subcutaneous abdominal fat ratio is associated with nonalcoholic fatty liver disease and liver fibrosis. Endocrinol Metab (Seoul) 2020;35:165-76.
[CROSSREF] [PUBMED] [PMC]
34. Rhee EJ, Lee WY, Cho YK, Kim BI, Sung KC. Hyperinsulinemia and the development of nonalcoholic fatty liver disease in nondiabetic adults. Am J Med 2011;124:69-76.
[CROSSREF] [PUBMED]
35. Lee DY, Rhee EJ, Chang Y, Sohn CI, Shin HC, Ryu S, et al. Impact of systemic inflammation on the relationship between insulin resistance and all-cause and cancer-related mortality. Metabolism 2018;81:52-62.
[CROSSREF] [PUBMED]
36. Lee SH, Kim MK, Rhee EJ. Effects of cardiovascular risk factor variability on health outcomes. Endocrinol Metab (Seoul) 2020;35:217-26.
[CROSSREF] [PUBMED] [PMC]
37. Rhee EJ, Han K, Ko SH, Ko KS, Lee WY. Increased risk for diabetes development in subjects with large variation in total cholesterol levels in 2,827,950 Koreans: a nationwide population-based study. PLoS One 2017;12:e0176615.
[CROSSREF] [PUBMED] [PMC]
38. Rhee EJ, Cho JH, Kwon H, Park SE, Park CY, Oh KW, et al. Increased risk of diabetes development in individuals with weight cycling over 4 years: the Kangbuk Samsung Health study. Diabetes Res Clin Pract 2018;139:230-8.
[PUBMED]
39. Hempe JM, Gomez R, McCarter RJ Jr, Chalew SA. High and low hemoglobin glycation phenotypes in type 1 diabetes: a challenge for interpretation of glycemic control. J Diabetes Complications 2002;16:313-20.
[PUBMED]
40. McCarter RJ, Hempe JM, Gomez R, Chalew SA. Biological variation in HbA1c predicts risk of retinopathy and nephropathy in type 1 diabetes. Diabetes Care 2004;27:1259-64.
[CROSSREF] [PUBMED]
41. Rhee EJ, Cho JH, Kwon H, Park SE, Park CY, Oh KW, et al. Association between coronary artery calcification and the hemoglobin glycation index: the Kangbuk Samsung Health Study. J Clin Endocrinol Metab 2017;102:4634-41.
[CROSSREF] [PUBMED]
42. Rhee EJ, Kwon H, Park SE, Han KD, Park YG, Kim YH, et al. Associations among obesity degree, glycemic status, and risk of heart failure in 9,720,220 Korean adults. Diabetes Metab J 2020;44:592-601.
[CROSSREF] [PUBMED] [PMC]
43. Rhee SY, Han KD, Kwon H, Park SE, Park YG, Kim YH, et al. Association between glycemic status and the risk of Parkinson disease: a nationwide population-based study. Diabetes Care 2020;43:2169-75.
[CROSSREF] [PUBMED] [PMC]